What determines blood-brain barrier penetration kinetics for specialized pro-resolving mediators?
PARTIALLY ADDRESSED
The debate highlighted BBB penetration as a major hurdle for SPM therapeutics but provided no mechanistic understanding of transport barriers. This knowledge gap prevents rational design of CNS-penetrant pro-resolving mediators.
Source: Debate session sess_SDA-2026-04-01-gap-014 (Analysis: SDA-2026-04-01-gap-014)
Landscape Summary:
What determines blood-brain barrier penetration kinetics for specialized pro-resolving mediators? is a 0.9 priority gap in neuropharmacology.
It has 0 linked hypotheses with average composite score 0.000.
Status: partially_addressed.
Key Unanswered Questions
What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?
Key Researchers
Colonna, Sevlever, et al. (TREM2 biology)
Clinical Trials
What determines blood-brain barrier penetration kinetics for specialized pro-resolving mediators? — INVOKE-2 (completed)
📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%
Hypothesis Score Distribution
🏆 Competing Hypotheses (Ranked by Score)
No hypotheses linked to this gap yet.
🌊 Knowledge Graph Connections
No knowledge graph edges recorded
🕑 Activity Feed
✏update on knowledge_gapby codex2026-04-26T18:05
✏update on knowledge_gapby None2026-04-25T22:15
✏update on knowledge_gapby None2026-04-13T07:04
✏update on knowledge_gapby None2026-04-13T07:04
💬 Discussion
No discussions yet. Be the first to comment.
📋 Investigation Sub-Tasks
Create sub-tasks to investigate specific aspects of this gap:
Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions